Department of Cardiovascular Surgery, JA Hiroshima General Hospital, Hatsukaichi-shi, Hiroshima, Japan.
Department of Cardiovascular Surgery, JA Hiroshima General Hospital, Hatsukaichi-shi, Hiroshima, Japan.
Ann Vasc Surg. 2022 May;82:156-164. doi: 10.1016/j.avsg.2021.10.060. Epub 2021 Dec 7.
The aim of the study was to determine the prognostic significance of measurement of graft flow on the patency of distal bypass.
A retrospective analysis was performed for 208 distal bypasses (208 limbs, 170 patients) with a single segment great saphenous vein conducted in a nonreversed manner from January 2009 to December 2019 in Japan. Patient backgrounds, operative details (including intraoperative mean graft flow), hospital outcomes, and long-term outcomes were evaluated. The primary endpoints were the primary, assisted primary, and secondary patency of the distal bypass graft and the secondary endpoints were limb salvage and wound healing.
The median intraoperative graft flow was 18 [10-30] mL/min. The follow-up rate was 98% in a mean follow-up period of 31 ± 26 months. Primary, assisted primary, and secondary patency in the cohort were 51%, 72%, and 73% at 1 year, and 39%, 59%, and 61% at 3 years, respectively. In multivariate analysis, the independent risk factors for primary patency were low graft flow (P = 0.0022) and female sex (P = 0.0016), and those for secondary patency were also low graft flow (P = 0.0025) and female sex (P < .001). The cut-offs for graft flow predicting primary and secondary patency were both 16 mL/min. The limb salvage rate was 94% at 1 year and 89% at 3 years; and the wound healing rates were 55%, 71% and 84% at 3, 6, and 12 months, respectively. Limb salvage and wound healing were not significantly associated with intraoperative graft flow.
Intraoperative graft flow was an independent predictor for graft patency in distal bypass, but had no influence on limb salvage and wound healing. The cut-off value for the mean graft flow predicting primary and secondary patency was 16 mL/min.
本研究旨在确定测量移植物流量对远端旁路通畅性的预后意义。
对 2009 年 1 月至 2019 年 12 月在日本进行的 208 例(208 条肢体,170 例患者)采用非逆行单一节段大隐静脉的远端旁路手术进行回顾性分析。评估患者背景、手术细节(包括术中平均移植物流量)、住院结局和长期结局。主要终点是远端旁路移植物的主要、辅助主要和次要通畅率,次要终点是肢体挽救和伤口愈合。
术中移植物流量中位数为 18[10-30]ml/min。在平均 31±26 个月的随访期内,随访率为 98%。该队列中 1 年的主要、辅助主要和次要通畅率分别为 51%、72%和 73%,3 年分别为 39%、59%和 61%。多变量分析显示,主要通畅率的独立危险因素是低移植物流量(P=0.0022)和女性(P=0.0016),次要通畅率的独立危险因素也是低移植物流量(P=0.0025)和女性(P<0.001)。预测主要和次要通畅率的移植物流量临界值均为 16ml/min。1 年和 3 年的肢体挽救率分别为 94%和 89%;3、6 和 12 个月的伤口愈合率分别为 55%、71%和 84%。肢体挽救和伤口愈合与术中移植物流量无显著相关性。
术中移植物流量是远端旁路通畅性的独立预测因子,但对肢体挽救和伤口愈合无影响。预测主要和次要通畅率的平均移植物流量临界值为 16ml/min。